FEP参加者増加の試み
精神病の初回治療における治療出席率を高めるための金銭的インセンティブ: 非ランダム化適応型パイロット研究
Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 初期フェーズ 1
連絡先と場所
研究場所
-
-
North Carolina
-
Raleigh、North Carolina、アメリカ、27608
- University of North Carolina at Chapel Hill (ENCOMPASS Program)
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、アメリカ、19123
- PEACE Program, Horizon House, Inc.
-
Philadephia、Pennsylvania、アメリカ、19104
- University of Pennsylvania
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- For all participants, age ≥ 18 years old.
- For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
- For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form
Exclusion Criteria:
- For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
- For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:非ランダム化
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Acceptability of intervention measure (AIM)
時間枠:Change at 8 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Acceptability of intervention measure (AIM)
時間枠:Change at 6 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Acceptability of intervention measure (AIM)
時間枠:Change at 4 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 4 months
|
|
Feasibility of intervention measure (FIM)
時間枠:Change at 8 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Feasibility of intervention measure (FIM)
時間枠:Change at 6 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Feasibility of intervention measure (FIM)
時間枠:Change at 4 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 4 months
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Implementation Survey Response
時間枠:Change at 8 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 8 months
|
|
Implementation Survey Response
時間枠:Change at 6 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 6 months
|
|
Implementation Survey Response
時間枠:Change at 4 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 4 months
|
|
Motivation Survey Response
時間枠:Change at 8 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 8 months
|
|
Motivation Survey Response
時間枠:Change at 6 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 6 months
|
|
Motivation Survey Response
時間枠:Change at 4 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 4 months
|
|
Ethical Concern Survey Response
時間枠:Change at 8 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 8 months
|
|
Ethical Concern Survey Response
時間枠:Change at 6 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 6 months
|
|
Ethical Concern Survey Response
時間枠:Change at 4 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 4 months
|
その他の成果指標
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
attrition
時間枠:Change at 8 months
|
rate of attrition |
Change at 8 months
|
|
attrition
時間枠:Change at 6 months
|
rate of attrition |
Change at 6 months
|
|
attrition
時間枠:Change at 4 months
|
rate of attrition |
Change at 4 months
|
|
psychotic symptomology
時間枠:Change at 8 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
時間枠:Change at 6 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
時間枠:Change at 4 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 4 months
|
|
psychotic symptomology
時間枠:Change at 8 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
時間枠:Change at 6 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
時間枠:Change at 4 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 4 months
|
|
depression
時間枠:Change at 8 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 8 months
|
|
depression
時間枠:Change at 6 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 6 months
|
|
depression
時間枠:Change at 4 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 4 months
|
|
quality of life
時間枠:Change at 8 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 8 months
|
|
quality of life
時間枠:Change at 6 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 6 months
|
|
quality of life
時間枠:Change at 4 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 4 months
|
|
recovery
時間枠:Change at 8 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 8 months
|
|
recovery
時間枠:Change at 6 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 6 months
|
|
recovery
時間枠:Change at 4 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 4 months
|
|
treatment motivation (intrinsic versus extrinsic)
時間枠:Change at 8 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 8 months
|
|
treatment motivation (intrinsic versus extrinsic)
時間枠:Change at 6 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 6 months
|
|
treatment motivation (intrinsic versus extrinsic)
時間枠:Change at 4 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 4 months
|
|
Perceived coercion
時間枠:Change at 8 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 8 months
|
|
Perceived coercion
時間枠:Change at 6 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 6 months
|
|
Perceived coercion
時間枠:Change at 4 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 4 months
|
|
attendance rate
時間枠:Change over 8 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change over 8 months
|
|
attendance rate
時間枠:Change at 6 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 6 months
|
|
attendance rate
時間枠:Change at 4 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 4 months
|
協力者と研究者
協力者
協力者
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- 2023-03
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。